miRagen Therapeutics, Inc. is a biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA (miRNA)—based therapeutics for cardiovascular and muscle disease. Located in Boulder, Colorado, miRagen was founded  by CEO Bill Marshall, two of the world’s leading cardiology researchers Mike Bristow and  Eric Olson, and investors Atlas Ventures and Boulder Ventures.  http://www.miragentherapeutics.com/

< Back to Portfolio